Vectors TRIZ Cases
- AAV Capsid Peptide Inserts for CNS and Muscle Tropism
Targeted peptide inserts in AAV capsids improve CNS and muscle transduction while helping evade pre-existing neutralizing antibodies.
- Liver-Specific Cis-Regulatory Elements for High-Expression Gene Therapy
Synthetic liver-specific enhancer elements boost hepatic gene expression in compact vectors while minimizing off-target expression.
- Mutant rtTA Transactivators for Low-Leakage Tet-On Gene Control
Four rtTA mutations improve tetracycline sensitivity and suppress Tet-On leakiness, enabling tighter and less toxic transgene expression.
- Plasmid Addiction via Succinate Pathway for Antibiotic-Free Retention
A succinate-pathway balanced lethal strategy keeps expression plasmids in daughter cells without antibiotics, lowering fermentation cost.
- Corynebacterium Promoter Engineering for Glycine and Glutamate Production
Modified promoter nucleotides boost HisE and HisG expression in Corynebacterium, raising glycine output while preserving glutamic acid productivity.
- Multi-Input miRNA Sensing Circuits for Cell-Type Classification
Constitutive ERN circuits classify cells from miRNA profiles while reducing toxicity and enabling rapid multi-output gene expression.
- CG-Rich β-Actin/CMV Promoter for Stable Recombinant Protein Expression
A CG-rich β-actin fragment placed upstream of CMV helps prevent promoter silencing and boosts recombinant antibody yield in CHO cells.
- UCP1-Regulated VGLL4 Construct for Brown Fat Expansion
A UCP1 enhancer-promoter drives VGLL4 expression in brown fat and liver cells to increase BAT, reduce WAT, and improve metabolic health.
- Capsid-Modified rAAV Vectors for MTC Cell-Specific Gene Delivery
Modified rAAV capsids and a truncated calcitonin promoter improve MTC cell transduction and targeted therapeutic gene expression.
- SRF-UCOE Chromatin Element for Stable Long-Term Transgene Expression
A compact SRF-UCOE keeps chromatin open to resist silencing, methylation, and position effects for durable transgene expression.
- gp120-Binding HIV-1 Antibodies for Broad Neutralization
Engineered gp120-binding sites target conserved HIV-1 epitopes to improve neutralization breadth, potency, and resistance to viral escape.
- AAV Capsid Variants for Antibody-Evasive CNS Gene Delivery
Specific AAV capsid amino acid changes improve CNS and liver tropism while helping vectors evade pre-existing antibody neutralization.
- Self-Replicating RNA Replicons for High Expression, Low Immunogenicity
Viral replicase and optimized UTR design boost self-replicating RNA expression while lowering immunogenicity and dose needs.
- Renal Artery Viral Vector Delivery for Targeted Glomerular Gene Transfer
Direct renal artery catheter infusion improves viral vector delivery to glomeruli and podocytes while limiting systemic spread.
- Dual-Vector Insulator Screening for Silencer-Free Genome Mapping
A dual-vector MAI-seq layout separates insulators from silencers, enabling accurate genome-wide screening across species.
- Globin Expression Cassettes With Insulators for Safer Gene Therapy
Enhancer-blocking insulators and modified globin control regions enable erythroid-specific expression while lowering insertional oncogenesis risk.
- Quorum-Sensing Auto-Induction for Balancing E. Coli Growth and Expression
A LuxI/LuxR promoter system auto-induces target gene expression in engineered E. coli, balancing growth and production without toxic inducers.
- Oncolytic Adenoviral Vector for Tumor-Selective Immune Activation
Hypoxia- and inflammation-responsive adenoviral replication improves tumor selectivity while CD40L and 4-1BBL boost antitumor immunity.
- VA RNA Promoter Design for Controlled rAAV Packaging Cell Lines
Inducible VA RNA transcription helps rAAV packaging cell lines avoid toxic rep/helper expression while improving production uniformity.
- Multi-circRNA AAV Constructs for High Tissue Expression
AAV delivery of tandem circRNA constructs with intronic elements and IRES boosts multi-circRNA expression across heart, liver, and muscle.
- Engineered M13 Phage Capture of SARS-CoV-2 at Low Viral Loads
Engineered M13 phages bind Spike S1 to capture and concentrate SARS-CoV-2 from samples, enabling sensitive detection at low viral loads.
- Self-Circularized RNA Structure for Longer Protein Expression
Group I self-splicing introns and stable end structures circularize RNA to resist exonuclease decay and extend protein expression.
- Gene-Silencing Composition for Plant Salt Stress Tolerance
Targeted inhibition of salt-response nucleotide sequences improves plant or algae survival and growth under high salinity.
- Codon 3-5 Sequence Tuning for Precise Protein Translation Control
Targeted nucleotide changes at codons 3, 4, and 5 tune protein abundance without changing amino acid sequence or using complex expression methods.
- Renal Artery Catheter Delivery of Viral Vectors to Glomeruli
Catheter infusion through the renal artery bypasses glomerular permselectivity to improve podocyte gene delivery with kidney-localized expression.
- Phi15 RNA Polymerase Expression in Pseudomonas With Low Toxicity
A phi15 phage RNAP and lysozyme expression strategy enables regulated, high-yield protein production in Pseudomonas without T7 toxicity.
- Modified NK-92 Cells With CD16 and IL-2 for ADCC Therapy
Engineered NK-92 cells add stable CD16 expression and intracellular IL-2 production to enable ADCC and avoid external IL-2 side effects.
- rAAV Vector Expression Control for GM1 and GM2 Gene Therapy
Engineered promoter-intron rAAV vectors tune HEXA, HEXB, or GLB1 expression to treat GM1 and GM2 disorders while reducing cytotoxicity.
- Cumate Inducible Promoter Architecture for Low-Leak Orthogonal Control
A reverse cumate activator and cumate repressor cut promoter leakiness and enable orthogonal multi-gene regulation without system interference.
- Self-Circularizing RNA Structure for Stable Therapeutic Expression
A self-splicing RNA construct forms circRNA to overcome mRNA instability, extending half-life while enabling rapid peptide and protein expression.
- AAV Immunoglobulin Gene Therapy for Persistent Rabies Neutralization
AAV vectors enable long-lasting anti-rabies antibody production, reducing multi-dose vaccination burden and intensive post-exposure care.
- Liver-Targeted AAV hASS1 Gene Therapy for Citrullinemia Correction
Liver-targeted AAV delivery of codon-optimized hASS1 lowers citrulline and ammonia, avoiding transplant immune suppression.
- FOXP3 And Helios eTregs for Stable T Cell Immunosuppression
Dual FOXP3 and Helios overexpression creates stable, purifiable eTregs that expand rapidly and suppress immune responses in GVHD.
- Anti-TnMUC1 CAR T-Cells With RDE Payload Control
RDE-controlled anti-TnMUC1 CAR T-cells time payload expression to limit toxicity while preserving long-term cancer surveillance.
- PKP2 Gene Therapy Vector for ARVC Desmosome Restoration
AAV9-mediated PKP2 delivery restores desmosome function in ARVC, helping prevent fibrofatty replacement, arrhythmias, and cardiac decline.
- Split Ribozyme RNA Biosensor for In Vivo Plant Expression Mapping
Guide RNAs assemble split ribozyme fragments on target RNA, enabling non-destructive in vivo plant expression mapping with visual output.
- Engineered AAV Capsids for Targeted Non-Liver Gene Delivery
Engineered AAV capsids improve non-liver transduction at lower doses, reducing liver toxicity and species-specific delivery gaps.
- Muscle-Specific Expression Cassettes for Tunable Gene Therapy Output
Modified regulatory cassettes tune gene expression across skeletal and cardiac muscle while limiting non-muscle expression and toxicity.
- Thiamine Analog Aptamers for Eukaryotic Riboswitch Gene Control
Engineered thiamine analog aptamers preserve ligand specificity while enabling riboswitch-based gene regulation in eukaryotic systems.
- Hairpin mRNA Production for Reliable Structured RNA Transcription
A polymerase-helicase PCR-IVT approach enables complete transcription of hairpin mRNA, improving structured RNA yield and stability.
- Split Protein Synthesis Inhibitor for Spatial and Temporal Control
A split RIP expression system keeps each component inactive alone, enabling cell-specific, reversible protein synthesis inhibition when both are expressed.
- Capsid-Modified rAAV3 Vectors for Higher Liver Cancer Transduction
Surface amino acid substitutions in rAAV3 capsids boost liver cancer cell transduction while lowering ubiquitination and particle demand.
- UO2F2 Bacterial Biosensors With Dual Uranium and Fluoride Sensing
Genetically modified bacterial biosensors combine U-sensitive promoters and F-sensing riboswitches to detect and neutralize bioavailable uranium.
- Inductive Hydrogel Beads for Localized Plant Shoot Regeneration
Localized hydrogel beads create an inducer gradient that triggers regeneration factors and helps plant tissues develop into mature shoots.
- Matrix Attachment Regions for Higher Mammalian Gene Expression
New MAR core and chimeric sequences bind the mammalian nuclear matrix to improve transcription, mRNA stability, and protein output.
- Aptamer Riboswitch Control of U1-Mediated Polyadenylation
Ligand binding reshapes an aptamer riboswitch to sequester the U1 site, enabling switchable polyadenylation and mRNA stability control.
- Synthetic Chromosome Gene Circuits With Multi-Gene Regulatory Control
A synthetic chromosome uses site-specific recombination to carry and regulate multiple genes, enabling complex circuits without viral payload limits.
- Renal Artery Catheter Infusion for Podocyte Gene Delivery
Direct catheter infusion into the renal artery improves viral vector delivery to glomeruli and podocytes while limiting liver expression.
- AAV Structural Plasmid Promoter Tuning for Higher Vector Titer
Promoter and Rep/Cap cassette tuning raises AAV vector titer while supporting purity and scalable suspension-cell production.
- Split Glutamine Synthetase Vectors for Balanced Antibody Expression
Split glutamine synthetase fragments link heavy and light chain expression, enabling faster selection of high-producing antibody cells.
- CRISPR GAA Gene Integration for Stable Pompe Disease Expression
CRISPR/Cas9 inserts a GAA repair template into liver cells to avoid AAV expression loss and sustain alpha-glucosidase production in Pompe disease.
- AAV-Rh74 Capsid Variants for Liver Gene Transfer Under Pre-Existing Immunity
Modified AAV-Rh74 capsids improve hepatocyte gene delivery and transgene expression while lowering anti-AAV immune response risk.
- Transgene Cassettes With miRNA-Regulated Epigenetic Silencers
miR-124, miR-338-3p, and miR-31 target sequences help restrict silencer expression while epigenetic effectors sustain cancer gene repression.
- Micro-Dystrophin Domain Selection for Cardiac Arrhythmia Protection
Segmented micro-dystrophin domains restore sodium currents in dystrophic Purkinje fibers and reduce cardiac arrhythmias.
- Viral Vector for Labeling and Killing Undifferentiated Stem Cells
A viral vector system links a marker gene and a suicide gene to label and remove undifferentiated stem cells.
- Episomal Vector System for Integration-Free iPSC Generation
Episomal vectors eliminate transgene removal steps by naturally losing plasmids during cell division, achieving high-yield integration-free stem cells.